EDN1 and systemic lupus erythematosus: ET-1, a pro-proliferative peptide, and thromboxane A2 (TXA-2), a lipid produced by activated platelets, are the main vasoconstrictors and their serum levels are elevated in patients with SLE-related PAH, along severity grade [19].